These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. FK419, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, ameliorates brain infarction associated with thrombotic focal cerebral ischemia in monkeys: comparison with tissue plasminogen activator. Maeda M; Moriguchi A; Mihara K; Aoki T; Takamatsu H; Matsuoka N; Mutoh S; Goto T J Cereb Blood Flow Metab; 2005 Jan; 25(1):108-18. PubMed ID: 15678117 [TBL] [Abstract][Full Text] [Related]
8. Prevention of experimental carotid and coronary artery thrombosis by the glycoprotein IIb/IIIa receptor antagonist CRL42796. Hennan JK; Hong TT; Willens DE; Driscoll EM; Giboulot TA; Lucchesi BR Br J Pharmacol; 2002 Jul; 136(6):927-37. PubMed ID: 12110617 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of arterial thrombus formation in two canine models: comparison of ancrod, a fibrinogen-depleting agent, the thrombin-inhibitor r-hirudin, and the glycoprotein 11b/IIIa-receptor antagonist Ro 43-8857. Rübsamen K; Hornberger W; Kirchengast M Thromb Haemost; 1995 Nov; 74(5):1353-60. PubMed ID: 8607122 [TBL] [Abstract][Full Text] [Related]
10. Functional relevance of the expression of ligand-induced binding sites in the response to platelet GP IIb/IIIa antagonists in vivo. Murphy NP; Pratico D; Fitzgerald DJ J Pharmacol Exp Ther; 1998 Aug; 286(2):945-51. PubMed ID: 9694954 [TBL] [Abstract][Full Text] [Related]
12. Prevention of thrombosis and enhancement of thrombolysis in rabbits by SR 121787, a glycoprotein II/III antagonist. Hoffmann P; Bernat A; Savi P; Herbert JM J Pharmacol Exp Ther; 1998 Aug; 286(2):670-5. PubMed ID: 9694919 [TBL] [Abstract][Full Text] [Related]
13. Glycoprotein IIb/IIIa receptor antagonist (2S)-2-[(2-Naphthyl-sulfonyl)amino]-3-[[2-([4-(4-piperidinyl)-2-[2-(4-piperidinyl)ethyl] butanoyl]amino)acetyl]amino]propanoic acid dihydrochloride (CRL42796), in combination with aspirin and/or enoxaparin, prevents coronary artery rethrombosis after successful thrombolytic treatment by recombinant tissue plasminogen activator. Hong TT; Driscoll EM; White AJ; Sherigill A; Giboulot TA; Lucchesi BR J Pharmacol Exp Ther; 2003 Aug; 306(2):616-23. PubMed ID: 12734394 [TBL] [Abstract][Full Text] [Related]
14. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets. Bednar RA; Gaul SL; Hamill TG; Egbertson MS; Shafer JA; Hartman GD; Gould RJ; Bednar B J Pharmacol Exp Ther; 1998 Jun; 285(3):1317-26. PubMed ID: 9618439 [TBL] [Abstract][Full Text] [Related]
15. The effects of two synthetic glycoprotein IIb/IIIa antagonists, Ro 43-8857 and L-700,462, on platelet aggregation and bleeding in guinea-pigs and dogs: evidence that Ro 43-8857 is orally active. Cook NS; Bruttger O; Pally C; Hagenbach A Thromb Haemost; 1993 Nov; 70(5):838-47. PubMed ID: 8128443 [TBL] [Abstract][Full Text] [Related]
16. Antiplatelet effect of FK633, a platelet glycoprotein IIb/IIIa antagonist, on thrombus formation and vascular patency after thrombolysis in the injured hamster carotid artery. Kaida T; Matsuno H; Niwa M; Kozawa O; Miyata H; Uematsu T Thromb Haemost; 1997 Mar; 77(3):562-7. PubMed ID: 9066011 [TBL] [Abstract][Full Text] [Related]
17. ME3277, a GPIIb/IIIa antagonist reduces cerebral infarction without enhancing intracranial hemorrhage in photothrombotic occlusion of rabbit middle cerebral artery. Kawano KI; Fujishima K; Ikeda Y; Kondo K; Umemura K J Cereb Blood Flow Metab; 2000 Jun; 20(6):988-97. PubMed ID: 10894182 [TBL] [Abstract][Full Text] [Related]
18. Prevention of rethrombosis after coronary thrombolysis in a chronic canine model. I. Adjunctive therapy with monoclonal antibody 7E3 F(ab')2 fragment. Rote WE; Mu DX; Bates ER; Nedelman MA; Lucchesi BR J Cardiovasc Pharmacol; 1994 Feb; 23(2):194-202. PubMed ID: 7511747 [TBL] [Abstract][Full Text] [Related]
19. Sildenafil improves coronary artery patency in a canine model of platelet-mediated cyclic coronary occlusion after thrombolysis. Lewis GD; Witzke C; Colon-Hernandez P; Guerrero JL; Bloch KD; Semigran MJ J Am Coll Cardiol; 2006 Apr; 47(7):1471-7. PubMed ID: 16580539 [TBL] [Abstract][Full Text] [Related]
20. Onset and extent of platelet inhibition by clopidogrel loading in patients undergoing elective coronary stenting: the Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial. Gurbel PA; Cummings CC; Bell CR; Alford AB; Meister AF; Serebruany VL; Am Heart J; 2003 Feb; 145(2):239-47. PubMed ID: 12595840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]